Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Meningitec
Active Ingredients: Diphtheria CRM 197 protein conjugate 15µg/dose
Meningococcal oligosaccharide - Group C 10µg/dose
Dosage Form: Suspension for injection
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturer: Berna Biotech AG, Berne, Switzerland
Product: MMR II Vaccine
Active Ingredients: Measles vaccine, live attenuated 1,000TCID50
Mumps vaccine 12,500TCID50
Rubella vaccine 1,000TCID50
Dosage Form: Suspension for injection Diluent
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Merck & Co Inc, West Point, Pennsylvania, United States of America
Dated this 16th day of February 2006.
GRAEME GILLESPIE, Acting-Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).